Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido van Amerongen

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Visualized Experiments : Jove|May 12, 2016
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task BatteryJustin L Hay, Pieter Okkerse, Guido van Amerongen, et al.
British Journal of Clinical Pharmacology|May 21, 2016
A literature review on the pharmacological sensitivity of human evoked hyperalgesia pain modelsGuido van Amerongen, Matthijs W de Boer, Geert Jan Groeneveld, et al.
Clinical and Translational Science|October 24, 2019
Lack of Detection of the Analgesic Properties of PF-05089771, a Selective Na<sub>v</sub> 1.7 Inhibitor, Using a Battery of Pain Models in Healthy SubjectsPieter Siebenga, Guido van Amerongen, Justin L Hay, et al.
Experimental Brain Research|May 5, 2016
Responsiveness of electrical nociceptive detection thresholds to capsaicin (8 %)-induced changes in nociceptive processingRobert J Doll, Guido van Amerongen, Justin L Hay, et al.
European Journal of Pain (London, England)|January 1, 2019
The ultraviolet B inflammation model: Postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjectsPieter S Siebenga, Guido van Amerongen, Erica S Klaassen, et al.
British Journal of Clinical Pharmacology|November 28, 2017
Demonstration of an anti-hyperalgesic effect of a novel pan-Trk inhibitor PF-06273340 in a battery of human evoked pain modelsPeter Loudon, Pieter Siebenga, Donal Gorman, et al.
European Journal of Pain (London, England)|February 23, 2019
Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugsPieter S Siebenga, Guido van Amerongen, Pieter Okkerse, et al.
British Journal of Anaesthesia|March 28, 2019
Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABA<sub>A</sub> partial agonist, in humansGuido van Amerongen, Pieter S Siebenga, Rachel Gurrell, et al.
British Journal of Clinical Pharmacology|November 19, 2016
The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover studyPieter Okkerse, Guido van Amerongen, Marieke L de Kam, et al.
Clinical Therapeutics|February 13, 2017
Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple SclerosisGuido van Amerongen, Kawita Kanhai, Anne Catrien Baakman, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Visualized Experiments : Jove|May 12, 2016
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task BatteryJustin L Hay, Pieter Okkerse, Guido van Amerongen, et al.
British Journal of Clinical Pharmacology|May 21, 2016
A literature review on the pharmacological sensitivity of human evoked hyperalgesia pain modelsGuido van Amerongen, Matthijs W de Boer, Geert Jan Groeneveld, et al.
Clinical and Translational Science|October 24, 2019
Lack of Detection of the Analgesic Properties of PF-05089771, a Selective Na<sub>v</sub> 1.7 Inhibitor, Using a Battery of Pain Models in Healthy SubjectsPieter Siebenga, Guido van Amerongen, Justin L Hay, et al.
Experimental Brain Research|May 5, 2016
Responsiveness of electrical nociceptive detection thresholds to capsaicin (8 %)-induced changes in nociceptive processingRobert J Doll, Guido van Amerongen, Justin L Hay, et al.
European Journal of Pain (London, England)|January 1, 2019
The ultraviolet B inflammation model: Postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjectsPieter S Siebenga, Guido van Amerongen, Erica S Klaassen, et al.
British Journal of Clinical Pharmacology|November 28, 2017
Demonstration of an anti-hyperalgesic effect of a novel pan-Trk inhibitor PF-06273340 in a battery of human evoked pain modelsPeter Loudon, Pieter Siebenga, Donal Gorman, et al.
European Journal of Pain (London, England)|February 23, 2019
Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugsPieter S Siebenga, Guido van Amerongen, Pieter Okkerse, et al.
British Journal of Anaesthesia|March 28, 2019
Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABA<sub>A</sub> partial agonist, in humansGuido van Amerongen, Pieter S Siebenga, Rachel Gurrell, et al.
British Journal of Clinical Pharmacology|November 19, 2016
The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover studyPieter Okkerse, Guido van Amerongen, Marieke L de Kam, et al.
Clinical Therapeutics|February 13, 2017
Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple SclerosisGuido van Amerongen, Kawita Kanhai, Anne Catrien Baakman, et al.
Pageof 2